Courtesy  Interfax

CHELYABINSK. Nov 1 (Interfax) – Representatives of the Sintez plant in the Kurgan region, part of the Binnopharm Group pharmaceutical holding owned by AFK Sistema , and members of a delegation from Sri Lanka have discussed options for interaction and international cooperation in the pharmaceutical sector, Binnopharm’s press service said.

“The Sintez Plant, which produces a wide range of medical products not only for the Russian market but also for foreign markets, is a potentially interesting partner for us,” Sri Lankan Ambassador to Russia Pakeer Mohideen Amza was quoted as saying.

Various options for cooperation are being considered, including procurement of medical products from Kurgan, establishing joint production, and using Sri Lanka as a hub for accessing the markets of neighboring countries in the region, he said.

“Binnopharm Group is actively moving into international markets,” CEO of PJSC Sintez Boris Zhorov said. “During the visit [of the Sri Lankan delegation to the Kurgan facility], it became clear that we have many points of contact, and it’s quite possible that Sri Lanka will become another partner for Binnopharm Group,” he said.

PJSC Sintez produces around 300 pharmaceutical products and is a major antibiotics producer in Russia. Approximately 35% of its medicines are produced in a full cycle from the company’s own pharmaceutical substances.

Binnopharm Group unites five production sites: JSC Alium (formerly Obolenskoe) in the Moscow region’s Serpukhov district, JSC Binnopharm, which has two sites in Zelenograd and Krasnogorsk, PJSC Sintez in Kurgan and JSC Biocom in Stavropol.